The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Ivenix selected Tritan MXF for the pump exterior because of its excellent chemical resistance and durability in the face of the aggressive disinfection protocols needed to prevent the spread of healthcare-associated infections
The company proposes to invest up to US $ 50 million, over a period of five years, starting from FY22, to support capability development of talent and technology
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
Barbara Engelhardt moves her computational and statistics lab to Gladstone
The institute will provide the world’s first unique and comprehensive capability to predict, prevent, respond and to recover from future pandemics
The company’s RenovoCath Delivery System designed for targeted treatment of solid tumours
The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion
Subscribe To Our Newsletter & Stay Updated
